Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Balcha G, Masresha"'
Autor:
Balcha G. Masresha, Messeret E. Shibeshi, Gavin B. Grant, Cynthia Hatcher, Charles S. Wiysonge
Publikováno v:
Vaccines, Vol 12, Iss 9, p 1069 (2024)
Introduction: To achieve global and regional measles elimination objectives, the World Health Organization (WHO) recommends coverage of 95% or higher with two doses of measles-containing vaccine. A second dose of measles-containing vaccine (MCV) is t
Externí odkaz:
https://doaj.org/article/814b77010f634b538e0aa3d1cd162746
Autor:
Balcha G. Masresha, Messeret E. Shibeshi, Roselina de Wee, Nicholas Shapumba, Takudzwa Sayi, Susan E. Reef, James L. Goodson
Publikováno v:
Vaccines, Vol 12, Iss 9, p 957 (2024)
Introduction: The WHO Measles and Rubella Strategic Framework 2021–2030 within the Immunization Agenda 2030 includes both measles and rubella elimination goals and provides guidance to countries for planning and implementing the measles and rubella
Externí odkaz:
https://doaj.org/article/6e6a9796458d491e9307de134e58d3ee
Publikováno v:
Vaccines, Vol 12, Iss 8, p 896 (2024)
The second dose of measles-containing vaccines (MCV2) has significant programmatic relevance in the current immunisation landscape because it serves as both an opportunity to reduce measles immunity gaps and strengthen second year of life vaccination
Externí odkaz:
https://doaj.org/article/88a9cb9208e640d0a3267e4c20dc84fa
Autor:
Balcha G. Masresha, Charles Shey Wiysonge, Reggis Katsande, Patrick Michael O’Connor, Emmaculate Lebo, Robert T. Perry
Publikováno v:
Vaccines, Vol 12, Iss 8, p 949 (2024)
Measles or rubella elimination is verified when endemic transmission of the corresponding virus has been absent for over 36 months in a defined area, in the presence of a well-performing surveillance system. This report updates the progress by 47 cou
Externí odkaz:
https://doaj.org/article/ce8e1b8e1f774214b9efef76a8279263
Autor:
Reinhard Kaiser,, Messeret E Shibeshi,, Jethro M Chakauya,, Emelda Dzeka,, Balcha G Masresha,, Fussum Daniel, Nestor Shivute
Publikováno v:
Bulletin of the World Health Organization, Vol 93, Iss 5, Pp 314-319 (2015)
Abstract Objective To assess the methods used in the evaluation of measles vaccination coverage, identify quality concerns and provide recommendations for improvement. Methods We reviewed surveys that were conducted to evaluate supplementary measles
Externí odkaz:
https://doaj.org/article/12b582c126a346aeaeb729bd5a9b0d45
Autor:
Fmoh Ethiopia, P.O. Box, Congo, Regional Office for Africa, Teklay K Desta, Ephrem T. Lemango, Jimma D Wayess, Addis Ababa, Brazzaville, Fmoh. P.O. Box, Balcha G Masresha Maternal
Publikováno v:
Journal of Immunological Sciences. 2:122-129
Background: Ethiopia endorsed the African Regional measles elimination goal and has been implementing the recommended strategies. Measles immunization coverage has been increasing but is still below the target, and measles incidence has remained high
Autor:
Jennifer L, Kriss, Roselina J, De Wee, Eugene, Lam, Reinhard, Kaiser, Messeret E, Shibeshi, Emmy-Else, Ndevaetela, Clementine, Muroua, Nicholaus, Shapumba, Balcha G, Masresha, James L, Goodson
Publikováno v:
Risk analysis : an official publication of the Society for Risk Analysis. 37(6)
In the World Health Organization (WHO) African region, reported measles cases decreased by 80% and measles mortality declined by 88% during 2000-2012. Based on current performance trends, however, focused efforts will be needed to achieve the regiona
Autor:
Jennifer B, Harris, Ousseynou, Badiane, Eugene, Lam, Jennifer, Nicholson, Ibrahim, Oumar Ba, Aliou, Diallo, Amadou, Fall, Balcha G, Masresha, James L, Goodson
Publikováno v:
Risk analysis : an official publication of the Society for Risk Analysis. 36(9)
The World Health Organization (WHO) African Region set a goal for regional measles elimination by 2020; however, regional measles incidence was 125/1,000,000 in 2012. To support elimination efforts, the WHO and U.S. Centers for Disease Control and Pr